WASHINGTON, July 22 (Reuters) – Johnson & Johnson Inc
subsidiary Acclarent Inc., a California-based medical
device manufacturer, has agreed to pay $18 million to resolve
allegations that it caused…

The post J&J unit Acclarent to pay $18 mln to settle false claims case appeared first on NASDAQ.